Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Assets (2018 - 2022)

NovaBridge Biosciences (NBP) has disclosed Assets for 5 consecutive years, with $572.8 million as the latest value for Q4 2022.

  • Quarterly Assets fell 34.62% to $572.8 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $572.8 million through Dec 2022, down 34.62% year-over-year, with the annual reading at $590.6 million for FY2022, 32.8% down from the prior year.
  • Assets for Q4 2022 was $572.8 million at NovaBridge Biosciences, down from $876.1 million in the prior quarter.
  • The five-year high for Assets was $955.7 million in Q4 2020, with the low at $246.5 million in Q4 2019.
  • Average Assets over 5 years is $598.9 million, with a median of $572.8 million recorded in 2022.
  • The sharpest move saw Assets skyrocketed 287.67% in 2020, then crashed 34.62% in 2022.
  • Over 5 years, Assets stood at $343.6 million in 2018, then decreased by 28.26% to $246.5 million in 2019, then surged by 287.67% to $955.7 million in 2020, then decreased by 8.33% to $876.1 million in 2021, then plummeted by 34.62% to $572.8 million in 2022.
  • According to Business Quant data, Assets over the past three periods came in at $572.8 million, $876.1 million, and $955.7 million for Q4 2022, Q4 2021, and Q4 2020 respectively.